Journal article 1469 views
Two Clinical Isolates of Candida glabrata Exhibiting Reduced Sensitivity to Amphotericin B Both Harbor Mutations inERG2
Antimicrobial Agents and Chemotherapy, Volume: 56, Issue: 12, Pages: 6417 - 6421
Swansea University Authors: Claire Hull, Josie Parker, Andrew Warrilow, Diane Kelly, Steven Kelly
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1128/aac.01145-12
Abstract
Two novel isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B (MIC 8 μg ml(-1)) were found to be erg2 mutants wherein Δ(8)-sterol intermediates comprised > 90% of the total cellular sterol fraction. Both harbored an alteration at Thr(121) in Erg2; the corresponding resid...
Published in: | Antimicrobial Agents and Chemotherapy |
---|---|
ISSN: | 0066-4804 1098-6596 |
Published: |
American Society for Microbiology
2012
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa13028 |
Abstract: |
Two novel isolates of Candida glabrata exhibiting reduced sensitivity to amphotericin B (MIC 8 μg ml(-1)) were found to be erg2 mutants wherein Δ(8)-sterol intermediates comprised > 90% of the total cellular sterol fraction. Both harbored an alteration at Thr(121) in Erg2; the corresponding residue (Thr(119)) in Saccharomyces cerevisiae is essential for sterol Δ8-Δ7 isomerization. This constitutes the first report of C. glabrata harboring mutations in ERG2 and exhibiting reduced sensitivity to amphotericin B. |
---|---|
College: |
Faculty of Medicine, Health and Life Sciences |
Issue: |
12 |
Start Page: |
6417 |
End Page: |
6421 |